Related Experiment Videos
Secretion of the terminal complement proteins, C5-C9, by human platelets
J J Houle1, J P Leddy, S I Rosenfeld
1University of Rochester Medical Center, Department of Medicine, New York 14642.
Clinical Immunology and Immunopathology
|March 1, 1989
Summary
Human platelets bind terminal complement proteins like C8 and C9. Upon activation, platelets release these proteins, suggesting a role in immune responses and platelet-dependent injury.
Area of Science:
- Immunology
- Hematology
- Complement System
Background:
- Platelets play a crucial role in hemostasis and immune responses.
- The complement system is a key part of innate immunity, involving a cascade of proteins.
- The interaction between platelets and the complement system is not fully understood.
Purpose of the Study:
- To investigate the association of terminal complement components with human platelets.
- To determine if complement components are released from platelets upon activation.
- To explore the potential functional significance of complement proteins on platelets.
Main Methods:
- Washed human platelets were incubated and then activated using collagen, thrombin, or aggregated IgG.
- Hemolytic assays were used to detect and quantify complement components (C5-C9) in platelet pellets and supernatants.
- Comparison of complement activity in platelet supernatants versus donor serum.
Main Results:
- Terminal complement components (C8, C9, C5, C6, C7) were found associated with resting human platelets.
- Platelet activation led to the release of these complement components into the supernatant.
- The hemolytic activity profile of released complement components differed significantly from serum, suggesting specific interaction rather than non-specific uptake.
Conclusions:
- Human platelets bind and release terminal complement components upon activation.
- The distinct release pattern suggests a specific functional role for platelet-associated complement.
- Released complement components may amplify platelet activation and contribute to inflammatory and immune-mediated tissue injury.